Simplex Trading’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-5,500
| Closed | – | – | 8674 |
|
|
2018
Q2 | $0 | Sell |
5,500
-1,800
| -25% | -$507 | ﹤0.01% | 8378 |
|
|
2018
Q1 | $1K | Sell |
7,300
-3,766
| -34% | -$3.47K | ﹤0.01% | 5996 |
|
|
2017
Q4 | $14K | Sell |
11,066
-6,237
| -36% | -$10.2K | ﹤0.01% | 3657 |
|
|
2017
Q3 | $36K | Buy |
17,303
+8,011
| +86% | +$19.5K | ﹤0.01% | 2615 |
|
|
2017
Q2 | $26K | Buy |
9,292
+2,352
| +34% | +$7.05K | ﹤0.01% | 3061 |
|
|
2017
Q1 | $23K | Buy |
+6,940
| New | +$27.4K | ﹤0.01% | 3134 |
|
|
2016
Q4 | – | Sell |
-2,455
| Closed | -$5.77K | – | 7237 |
|
|
2016
Q3 | $8K | Buy |
2,455
+1,936
| +373% | +$7.31K | ﹤0.01% | 3906 |
|
|
2016
Q2 | $2K | Sell |
519
-690
| -57% | -$3.12K | ﹤0.01% | 5159 |
|
|
2016
Q1 | $6K | Buy |
1,209
+1,129
| +1,411% | +$14.7K | ﹤0.01% | 4029 |
|
|
2015
Q4 | $1K | Buy |
+80
| New | +$1.91K | ﹤0.01% | 5256 |
|
|
2015
Q2 | – | Sell |
-261
| Closed | -$15.6K | – | 6566 |
|
|
2015
Q1 | $20K | Sell |
261
-1,050
| -80% | -$65.1K | ﹤0.01% | 2357 |
|
|
2014
Q4 | $79K | Buy |
+1,311
| New | +$65.9K | 0.01% | 1072 |
|
Simplex Trading's OREX Position: Q3 2018 in Review
Simplex Trading sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2018, closing a stake of 5,500 shares.
Simplex Trading first reported a position in OREX in Q4 2014 and held it in 12 quarters. The position peaked at $79K in Q4 2014. 1 fund tracked by Wall St. Rank holds OREX as of Q3 2018.
- Simplex Trading reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
- Simplex Trading sold 5,500 Orexigen Therapeutics, Inc. shares in Q3 2018.
- Simplex Trading first reported a position in Orexigen Therapeutics, Inc. in Q4 2014 and held it in 12 quarters.
- Simplex Trading's Orexigen Therapeutics, Inc. position peaked at $79K in Q4 2014.
- 1 fund tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2018.
Based on Simplex Trading's 13F filing for Q3 2018, filed 23 Oct 2018.